Sylvant® is a prescription medicine indicated for the treatment of adult MCD
(Multicentric Castleman Disease) patients who are HHV-8 and HIV negative.
This website is only intended for patients who are prescribed Sylvant®
December 2024 | GL-SYL-0173
© 2024 Recordati Rare Diseases – Registered in England No. 9329429
Registered office:
Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ
| Cookie Name | Purpose | Default Expiration Time | Status |
|---|---|---|---|
| accept-cookies | Used to determine if the user has accepted the use of Strictly necessary cookies | 30 Days from set | Always Activated |
| user | Used to determine if the user has selected if they are patients of Idiopathic multicentric Castleman disease (“iMCD”) | 30 Days from set | Always Activated |
You are now leaving the Recordati Rare Diseases website and entering an external site that is not under the review or control of Recordati Rare Diseases and, as such, Recordati Rare Diseases does not take responsibility for its accuracy or content.
Please confirm you wish to follow this link.
A rare disease like iMCD is defined as one that affects less than 5 in 10,000 of the general population. There are between 6,000 and 8,000 known rare diseases and around five new rare diseases are described in medical literature each week.
